GlobeNewswire by notified

RESULT OF RIKSBANK CERTIFICATE SALE

Share
AuctionAuction results
Auction date2023-01-10
Start date2023-01-11
Maturity date2023-01-18
Interest rate, %2.50
Offered volume, SEK bn585.0
Total bid amount, SEK bn3198.7
Accepted volume, SEK bn585.0
Number of bids16
Percentage allotted, %18.289


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer2.3.2024 18:41:17 CET | Press release

NON-REGULATORY PRESS RELEASE The NIPU trial is investigating the effect of adding UV1 vaccine to immunotherapy as second-line treatment of pleural mesothelioma. The results were initially presented at the ESMO Conference in October 2023The publication outlines the full trial results, including observations on UV1’s positive impact on objective response rate, overall survival, and additional data on increased efficacy in defined histological subtypes Oslo, March 2, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the results from the randomized controlled Phase II clinical trial, NIPU, are published in the European Journal of Cancer. The trial investigates the effect of adding Ultimovacs’ cancer vaccine UV1 to second-line treatment with ipilimumab and nivolumab for patients with pleural mesothelioma (NCT04300244). NIPU is an investigator-initiated, open-label, multi-center Phase II t

Fitch Affirms Iceland at ‘A’; Outlook Stable2.3.2024 09:40:00 CET | Press release

Fitch Ratings has affirmed Iceland’s Long-Term Foreign-Currency Issuer Default Rating (IDR) at ‘A’ with a Stable Outlook. Iceland's 'A' rating is underpinned by its very high income per capita and governance indicators that are more consistent with those of 'AAA' and 'AA' rated sovereigns. The country has built sizeable buffers, which help mitigate its vulnerability to external shocks and balance of payments' risks; including ample foreign reserves, and a fiscal cash buffer, which has been reduced in recent years. Strong credit fundamentals include the country's sizeable pension fund assets, sound banking sector, and strong private sector balance sheets. The rating remains constrained by Iceland's small size economy with its limited export diversification and high level of public debt. Increased confidence in a sharp and sustained decline in the government debt/GDP ratio, higher trend growth and/or evidence of economic diversification that reduces Iceland's vulnerability to external sh

World Trade Organization Continues to Allow Subsidized Overfishing2.3.2024 01:06:35 CET | Press release

Oceana says the WTO is playing politics with the lives of millions of people who depend on healthy fish populations for their livelihoods and food security WASHINGTON, March 01, 2024 (GLOBE NEWSWIRE) -- This week, at the World Trade Organization’s (WTO) 13th ministerial conference in Abu Dhabi, ministers were unable to finalize an addendum to its Agreement on Fisheries Subsidies that had the potential to curb harmful fisheries subsidies that lead to overfishing. This setback extends the WTO’s two-decade-long streak of failing to prohibit harmful subsidies, a commitment it first took up at the 2001 Doha Ministerial Conference. Oceana’s Senior Analyst Dr. Daniel Skerritt says, “This outcome is not just disappointing; it’s a dire blow to global marine biodiversity. Our governments are failing to look beyond their own short-term self-interest, prioritizing political posturing above reaching an agreement that would benefit everyone. The WTO’s continued failure to prohibit subsidy-driven ove

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons2.3.2024 00:04:01 CET | Press release

Company Announcement COPENHAGEN, Denmark; March 02, 2024 –Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in Genmab shares by the company’s managerial employees and their closely associated persons. This company announcement includes the vesting and net settlement of the restricted stock units granted to Jan van de Winkel and Anthony Pagano on February 26, 2021. Please find below a statement of such trading in shares issued by Genmab A/S 1.Details of the person discharging managerial responsibilities / person closely associateda)NameJan van de Winkel2.Reason for the notificationa)Position/statusPresident &

Remuneration of Directors and Executives by distribution of Millicom (Tigo) shares1.3.2024 22:30:00 CET | Press release

Remuneration of Directors and Executives by distribution of Millicom (Tigo) shares Luxembourg, March 1, 2024 – Millicom International Cellular S.A. ("Millicom") announces that, in accordance with the vesting terms and conditions of its deferred share-based compensation plans, approved at Millicom’s 2021, 2022, and 2023 annual general meetings of shareholders, it has distributed treasury shares to eligible plan participants, including 193,702 shares to its executive management. Details of the distributions are disclosed on Millicom’s website. For further information, please contact: Press: Sofía Corral, Communications Director press@millicom.comInvestors: Michel Morin, VP Investor Relations investors@millicom.com About Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of fixed and mobile telecommunications services in Latin America. Through our TIGO® and Tigo Business® brands, we provide a wide range of digital services and products, including TIGO

HiddenA line styled icon from Orion Icon Library.Eye